dorsaVi (ASX: DVL) has taken a significant step toward the next generation of intelligent wearables and robotics with the acquisition of a neuromorphic technology portfolio from researchers at Technion – Israel Institute of Technology, led by Professor Shahar Kvatinsky, a global authority in Processing-in-Memory and adaptive hardware systems. …
dorsaVi secures breakthrough neuromorphic technology to power next-generation wearables and robotics
November 12, 2025 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 - - Latest News -
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 - - Latest News -
Mark Butler steps in to block eye injection funding change after patient warnings
March 10, 2026 - - Latest News -
Pharmac says new agreement has improved access to treatment for New Zealanders
March 10, 2026 - - Latest News -
Island Pharmaceuticals expands antiviral program through Burnet Institute collaboration
March 9, 2026 - -
New cancer research highlights potential of narmafotinib to koost KRAS Inhibitor therapies
March 9, 2026 - - Australian Biotech -
Lateral Pharma secures key U.S. patent for novel neuropathic pain therapy
March 9, 2026 - - Australian Biotech